Chemed Q2 Adj $5.47 Misses $5.59 Estimate, Sales $595.88M Miss $599.19M Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemed (NYSE:CHE) reported Q2 earnings of $5.47 per share, missing the analyst estimate of $5.59. Sales were $595.88M, also below the $599.19M estimate. Despite the misses, earnings and sales increased year-over-year by 34.07% and 7.60%, respectively.
July 24, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemed's Q2 earnings and sales missed analyst estimates, but both metrics showed significant year-over-year growth. The stock may face short-term pressure due to the misses, despite the positive growth.
Chemed's earnings and sales both missed analyst estimates, which typically results in short-term negative sentiment. However, the strong year-over-year growth in both earnings and sales may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100